First Pharmaceutical Holdings (688197.SH) released its 2023 annual performance report. During the reporting period, the company achieved an operating income of 5...
According to Zhitong Finance App News, First Pharmaceutical Holdings (688197.SH) released its 2023 annual performance report. During the reporting period, the company achieved operating income of 5,2292 million yuan, an increase of 186.18% over the previous year; net loss attributable to shareholders of listed companies of 186 million yuan; net loss attributable to shareholders of listed companies after deducting non-recurring profit and loss of 199 million yuan; and a basic loss of 1.25 yuan per share.